HR 3851
Access to Breast Cancer Diagnosis Act of 2023
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This bill, the Access to Breast Cancer Diagnosis Act of 2023, prohibits health plans and insurers from requiring cost-sharing – such as deductibles or copays – for diagnostic and supplemental breast examinations. It ensures that these screenings and evaluations are covered without out-of-pocket expenses for individuals enrolled in health plans. The bill also makes adjustments to existing healthcare laws to strengthen these protections and apply them to certain types of health plans, effective January 1, 2024.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Abigail Davis Spanberger
Ann M. Kuster
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.